-
Point-of-care authorized
-
High-reliability CHF assessment and diagnosis
-
Risk stratification for ACS
-
Short processing times
-
Analyzed & displayed by the Triage Meter systems .
The Quidel Corporation Triage BNP Test is a rapid fluorescence immunoassay that aids in detecting congestive heart failure (CHF) and acute coronary syndrome (ACS).
Quick & Reliable Cardiology Screening The Triage BNP is a pioneering rapid assay for B-type natriuretic peptide in EDTA anticoagulated whole blood and plasma. This marker is highly suited for assessing and diagnosing CHF and risk stratification for patients with ACS. Additionally, with the 15-minute processing times, patient care decisions can be attended to earlier, improving clinical and economic outcomes.
The Quidel Corporation Triage BNP Test is a trusted partner in cardiovascular health screening.
WARNING: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.